Axsome acquires Avenue's subsidiary for epilepsy drug development
Go back to Axsome acquires Avenue's subsidiary for epilepsy drug development| (NASDAQ: ATXI) | Delayed: 0.42 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.42 | 52 Week High | $ | |||
| Open | $0.42 | 52 Week Low | $ | |||
| Day High | $0.42 | P/E | N/A | |||
| Day Low | $0.42 | EPS | $ | |||
| Volume | 30,817 | |||||
| (NASDAQ: AXSM) | Delayed: 220.75 +9.64 (4.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $211.11 | 52 Week High | $15.74 | |||
| Open | $212.71 | 52 Week Low | $5.37 | |||
| Day High | $229.62 | P/E | N/A | |||
| Day Low | $212.44 | EPS | $0.00 | |||
| Volume | 1,228,404 | |||||
| Fabien Corp (NASDAQ: FBIO) | Delayed: 2.52 -0.05 (1.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.57 | 52 Week High | $4.66 | |||
| Open | $2.59 | 52 Week Low | $2.01 | |||
| Day High | $2.62 | P/E | N/A | |||
| Day Low | $2.52 | EPS | $0.00 | |||
| Volume | 209,602 | |||||

